Company / Depreciation & Amortization
Serina Therapeutics, Inc. Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$100.0K
FY2025
5-year range
$90.0K / $100.0K
FY2021-FY2025
Trend
+11.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $90,000 to $100,000 over the past 2 years.
Based on SEC 10-K filings.
$100,000 in FY2025 with a 5-year CAGR of -23.9%.
Increased from $90,000 to $100,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -23.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -23.9%, indicating a declining trend.
- In FY2025, depreciation & amortization increased 11.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $100.0K | +11.1% |
| FY2024 | $90.0K | +0.0% |
| FY2023 | $90.0K | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $393.0K | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026